Form 4: Danaher Corp Director Jessica L. Mega Reports Stock and Option Awards
SEC Form 4 Filing
Director Jessica L. Mega reported the acquisition of restricted stock units and stock options in Danaher Corp on May 15, 2024.
Summary
- Jessica L. Mega, a director of Danaher Corp, reported acquiring 390 shares of common stock in the form of restricted stock units (RSUs) on May 15, 2024.
- These RSUs were granted by Danaher Corporation and are payable solely in common stock.
- The RSUs vest on the earlier of the first anniversary of the grant date or the date immediately prior to the next annual meeting of Danaher's shareholders.
- The underlying shares are not issued until the earlier of the director's death or the first day of the seventh month following the director's retirement from the Board.
- Mega also acquired stock options (right to buy) for 1,081 shares of common stock at an exercise price of $263.46 on the same date.
- These options are exercisable from May 15, 2024, and expire on May 15, 2034.
- Following these transactions, Mega directly owns 2,725 shares of common stock and options for 1,081 shares.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of stock and option awards to a director, indicating alignment of interests but not necessarily a strong positive or negative signal.
Positives
- The acquisition of RSUs and stock options by a director signals confidence in the company's future performance.
Future Outlook
The document does not contain specific forward-looking statements about Danaher's future performance, but the granting of RSUs and stock options to a director suggests an expectation of continued growth and value creation.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors as they can provide insights into management's sentiment about the company's prospects.
Comparison to Industry Standards
- Stock option and RSU grants are a common form of executive compensation in publicly traded companies like Danaher.
- The vesting schedules and terms of these grants are generally in line with industry standards, designed to align management's interests with those of shareholders over the long term.
- Comparable companies such as Thermo Fisher Scientific and Abbott Laboratories also utilize stock options and RSUs as part of their executive compensation packages.
Stakeholder Impact
- The granting of RSUs and stock options aligns the director's interests with those of shareholders, incentivizing them to work towards increasing shareholder value.
Key Dates
| Date | Description |
|---|---|
| 05/15/2024 | Date of the transaction: acquisition of restricted stock units and stock options. |
| 05/15/2024 | Date the director stock options become exercisable. |
| 05/15/2034 | Expiration date of the director stock options. |
| 05/17/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.